This image provided by Pfizer shows its covid-19 pills. Drugmaker Pfizer said Tuesday it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks. (COURTESY OF PFIZER)
WASHINGTON — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for covid-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at ...
Premium Content is available to subscribers only. Please login here to access content or go here to purchase a subscription.
